The short answer: probably not. For decades, ketamine carried a reputation as a drug that dangerously raises intracranial pressure, but modern evidence has largely overturned that belief. In systematic reviews of traumatic brain injury patients, four studies found ketamine actually lowered ICP, five found no significant change, and only two reported increases. The old warning persists in some guidelines and textbooks, but the clinical picture is far more nuanced than “ketamine raises ICP.”
Where the Old Belief Came From
Ketamine was introduced as an anesthetic in the 1970s, and early observations suggested it increased pressure inside the skull. Those early studies had a critical flaw: they were conducted on patients breathing on their own, without controlled ventilation. This matters enormously because ketamine can cause slight changes in breathing patterns, and when breathing slows or becomes shallow, carbon dioxide builds up in the blood. Rising CO2 dilates blood vessels in the brain and raises intracranial pressure.
An animal study illustrates this clearly. Piglets breathing spontaneously after receiving ketamine saw their ICP climb from about 32 to 39 mmHg, with dangerous spikes in blood CO2. But piglets on controlled ventilation, where CO2 stayed stable, actually experienced a drop in ICP. The correlation between CO2 levels and intracranial pressure was statistically significant at every ketamine dose tested. In other words, ketamine wasn’t raising ICP directly. The real culprit was uncontrolled CO2.
What Modern Evidence Shows
When researchers revisit ketamine under the conditions it’s actually used today (patients on ventilators with careful monitoring), the picture flips. A systematic review in the International Journal of Critical Illness and Injury Science examined multiple studies of ketamine in traumatic brain injury patients. Four studies found a statistically significant decrease in ICP. Two found an increase. Five found no correlation between ketamine doses and ICP changes at all. The overall takeaway: ketamine does not reliably raise intracranial pressure, and in many cases it lowers it.
A prospective, double-blinded study comparing continuous ketamine sedation to propofol in severe traumatic brain injury patients found that ICP stayed within normal range in both groups. But the ketamine group fared better on several other measures. Eighty percent of patients receiving propofol needed additional blood pressure medications to keep cerebral perfusion pressure above 60 mmHg, compared to significantly fewer in the ketamine group. Episodes where ICP spiked above safe thresholds occurred only in the propofol group. And critically, three patients in the propofol group experienced neurological worsening during their hospital stay, compared to zero in the ketamine group.
Why Ketamine Can Actually Help Brain Perfusion
Ketamine tends to raise blood pressure slightly, which is often considered a drawback in other contexts but becomes an advantage in brain injury. Cerebral perfusion pressure (the pressure driving blood flow to the brain) equals mean arterial pressure minus intracranial pressure. If ketamine raises blood pressure without raising ICP, the net effect is better blood flow to the brain. One study found a modest CPP increase of about 3.9 mmHg after a ketamine bolus, lasting around two minutes, with no adverse effects.
This hemodynamic profile means patients on ketamine often need fewer vasopressors, the powerful blood pressure drugs commonly required in intensive care. In the head-to-head trial against propofol, rescue vasopressor use was needed only in the propofol group. For patients with brain injuries who are already hemodynamically fragile, avoiding additional blood pressure drugs is a meaningful clinical benefit. Ketamine also caused less bradycardia (dangerously slow heart rate) and fewer ventilator-related complications than propofol in the same study.
Pediatric Findings
A study at a tertiary children’s hospital examined 127 ketamine doses given to 33 children (ages one month to 16 years) with severe traumatic brain injuries who had ICP monitors in place. When ketamine was given for routine sedation, there was no significant change in ICP or perfusion pressure from baseline. More striking: when ketamine was given during active ICP crises (18 doses across 11 patients), intracranial pressure dropped and perfusion pressure rose. The authors concluded that ketamine may even warrant consideration as a treatment for dangerous ICP spikes in children with severe brain injuries, pending larger confirmatory studies.
Ketamine’s Protective Effects on Brain Cells
Beyond its effects on pressure, ketamine blocks a specific type of receptor in the brain that, when overstimulated, allows too much calcium to flood into nerve cells and kill them. This process, called excitotoxicity, is a major driver of secondary brain damage after trauma. By blocking these receptors, ketamine may reduce the cascade of cell death that follows the initial injury. Animal studies using doses ranging from 5 to 45 mg/kg have shown substantial reductions in neurodegeneration and inflammatory cell activation in the brain. Ketamine also appears to activate growth-promoting signaling pathways in neurons through mechanisms that go beyond simple receptor blockade.
Why the Warning Still Appears in Some Guidelines
Despite the accumulating evidence, some clinical guidelines still carry cautionary language about ketamine and ICP. The Brain Trauma Foundation’s field guidelines for combat-related head trauma, for instance, note that there is “some evidence to support the possibility” that ketamine and opioids may increase ICP. That phrasing reflects the older literature and the reality that prehospital settings often lack the ventilation control and monitoring that make ketamine safe. In a field environment where you can’t monitor CO2 levels or control ventilation, the concern about respiratory-driven ICP spikes is more legitimate.
The gap between field guidelines and ICU evidence is important. In a controlled hospital setting with mechanical ventilation and continuous monitoring, ketamine’s ICP profile looks favorable. In an unmonitored prehospital scenario, the risk of CO2 buildup from changes in breathing remains real. Context determines whether the old concern applies.
The Bottom Line on Ketamine and ICP
The belief that ketamine categorically raises intracranial pressure is outdated. It was based on studies where CO2 levels weren’t controlled, and it doesn’t hold up under modern clinical conditions. In ventilated patients with brain injuries, ketamine either has no effect on ICP or modestly lowers it, while supporting blood pressure and brain perfusion in ways that competing sedatives often don’t. The drug’s reputation is shifting from “avoid in head injuries” to “potentially beneficial in head injuries,” though the evidence base is still building and study results remain somewhat mixed.